Global Deep brain stimulation Market is valued USD 795.64 million in 2016 is anticipated to grow USD 2119.3 million with the compounded annual growth of 11.5% over the forecast period 2017-2025.
New York 30 June 2018, As per the new research study conducted by Bizwit Research & Consulting, Global Deep brain stimulation industry is poised to raise USD 2119.3 million by 2025. Some key components for the market development will be; Expanding predominance of neurological ailments, for example, Parkinson’s ailment, epilepsy, fundamental tremor, and dystonia, is one of the key patterns advancing business sector development.
To view the summary or to request a sample copy of this report, please click the link mentioned below:
The industry seems to be fairly competitive. Some of the leading market players include 3M Medtronic Plc., Boston scientific and so on. Other market players discussed in the report include Jude medical Inc., Aleva Neurotherapeutics SA.New product launches, acquisitions, and mergers are some of the strategies adopted by the key manufacturers. Additionally, the fierce competitiveness has made these players spend in product developments to improve the customer’s requirements.
Key findings of the study:
- Increasing prevalence of the disease is the primary factor contributing to the growth of the segment.
- Asia Pacific is expected to be the most promising destination for DBS manufacturers during the forecast period.
- Rising prevalence of neurodegenerative and psychiatric disorders coupled with high unmet demand for effective and long-term treatment solutions is anticipated to supplement the growth of the regional market.
Bizwit Research & Consulting LLP has considered following segments for the study:
- Pain management
- Essential tremor
- North America
- Asia Pacific
- Latin America
- Rest of the World